Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Clemson University
With
Madigan Army Medical Center
U.S. Army Medical Research and Development Command
Multi-site phased study, conducted within the Military Health System that includes a user-centered design phase and a patient centered medical home (PCMH)-based feasibility trial.
In Phase I the investigators will assess both patient and clinician preferences and usability regarding the enhancement of the enabling technology capabilities for Type 2 diabetes chronic self-care management. The data from the experience will be coded and analyzed by the research team and the technology will be adapted accordingly before Phase II.
Phase II research is a single-blinded 12-month feasibility study that seeks to include the enabling technology to support diabetes self-care management with tailored behavioral messaging aimed at reinforcing and encouraging self-care behavior based on patients' readiness. We have included safety thresholds that alert patients and clinical team under certain conditions.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Men and women age 18 years or older,
Ability to understand and read English,
Be empanelled to one of the target PCMH sites, and
Diagnosed with type 2 diabetes.
You may not be if
pregnant women,
non-English speaking patients,
receiving hospice care,
active cancer and treatment with chemotherapy or radiation therapy,
taking Coumadin,
recipient of gastric bypass or similar procedure,
diagnosis of uncontrolled hypothyroidism,
known Cushing's syndrome,
being treated with oral steroids,
known liver disease,
current diagnosis of cognitive impairments which would interfere with use of technology,
congestive heart failure New York Heart Association class 3 or 4,
inability to use a mobile device due to cognitive or physical impairments, and
PAM® score = 4 during initial screening.
Clareo Health | Enhancing mHealth Technology to Activate Chronic Care Patients
